Glucotrack Prices $3.1M Registered Direct Offering at $2.04/Share
GCTK sits 33% above its 52-week low of $1.998 on elevated volume (25× avg).
Summary
Glucotrack priced a $3.1 million registered direct offering at $2.04 per share, with proceeds earmarked for debt repayment and working capital. The deal adds up to 1,519,608 shares on a fully-exercised basis, a substantial increase relative to the current share count.
Key Events · Financing and Capital Events · GCTK
-
Registered Direct Offering Priced
169,388 shares at $2.04 per share plus pre-funded warrants for 1,350,220 shares at $2.039 per warrant, for gross proceeds of approximately $3.1 million.
-
Dilution Impact
The offering adds up to 1,519,608 shares of common stock on a fully-exercised basis, a substantial increase relative to the 848,629 shares currently outstanding.
-
Use of Proceeds
Net proceeds of approximately $2.85 million will repay $1,341,288 of Bridge Notes (8% interest, maturing April 14, 2027), with the remainder for working capital.
-
Placement Agent Compensation
Dawson James Securities will receive an 8.0% cash fee on gross proceeds ($248,000), plus expense reimbursements up to $50,000.
Analysis · GCTK · Industrial Applications And Services
A $3.1 million registered direct offering priced at $2.04 per share—just above the $2.03 last reported sale price on September 23, 2026—is being used by Glucotrack to raise capital. The deal includes 169,388 shares of common stock and pre-funded warrants for 1,350,220 shares, adding up to 1,519,608 shares on a fully-exercised basis, a substantial increase relative to the 848,629 shares currently outstanding. Net proceeds of approximately $2.85 million will repay $1,341,288 of Bridge Notes and fund working capital. This financing comes amid a cash crisis, going concern doubt, and Nasdaq delisting risk disclosed in the Q2 10-Q, making the capital raise a survival move rather than a growth investment.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.9% of the 1661 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GCTK was trading at $2.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1M. The 52-week trading range was $2.00 to $136.29. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.